Joost van der Mark
Corporate Officer/Principal bij BIOSYENT INC.
Vermogen: 338 263 $ op 31-03-2024
Actieve functies van Joost van der Mark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOSYENT INC. | Corporate Officer/Principal | 10-09-2018 | - |
Loopbaan van Joost van der Mark
Eerdere bekende functies van Joost van der Mark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TELO GENOMICS CORP. | Corporate Officer/Principal | 06-01-2017 | 31-05-2018 |
| BIOSYENT INC. | Corporate Officer/Principal | 01-08-2015 | 01-01-2017 |
| KNIGHT THERAPEUTICS INC. | Corporate Officer/Principal | - | - |
Orphan Canada, Inc.
 Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Founder | - | - |
| Corporate Officer/Principal | - | - |
Opleiding van Joost van der Mark
| York University | Masters Business Admin |
| University of Western Ontario | Graduate Degree |
| The Schulich School of Business | Masters Business Admin |
Statistieken
Internationaal
| Canada | 8 |
Operationeel
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 2 |
| Founder | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BIOSYENT INC. | Health Technology |
| KNIGHT THERAPEUTICS INC. | Health Technology |
| TELO GENOMICS CORP. | Health Services |
| Bedrijven in privébezit | 1 |
|---|---|
Orphan Canada, Inc.
Orphan Canada, Inc. Pharmaceuticals: MajorHealth Technology Part of Knight Therapeutics, Inc., Orphan Canada, Inc. is a Canadian company that manufactures specialty pharmaceuticals. The private company was founded by Jason Flowerday, Joost van der Mark. Orphan Canada was acquired by Knight Therapeutics, Inc. on September 02, 2014. | Health Technology |
- Beurs
- Insiders
- Joost van der Mark
- Ervaring
